Literature DB >> 12199865

Characterization of baboon anti-porcine IgG antibodies during acute vascular rejection of porcine kidney xenograft.

Jean-Paul Dehoux1, Bernardo de la Parra, Dominique Latinne, Hervé Bazin, Pierre Gianello.   

Abstract

In the pig-to-baboon model, the removal of anti-porcine natural antibodies abrogates hyperacute vascular rejection (HAVR), but the xenograft then undergoes an acute vascular rejection (AVR) concomitantly to the appearance of newly formed anti-porcine antibodies. The use of anti-IgM monoclonal antibody (mAb) in baboons allowed to avoid HAVR of pig-to-baboon renal xenografts, but, at post-operative day 6, AVR occurred because of a rapid return of anti-porcine antibodies. The aim of this work was to characterize the anti-porcine antibodies during AVR. Sera from anti-IgM-treated animals were assessed prior to the graft and at the time of AVR by enzyme linked immunosorbent assay (ELISA) to determine anti-porcine antibodies concentration as well as the IgG subtypes. The same sera were tested on confluent cultures of porcine aortic endothelial cells (PAECs) to assess (i) the cytolytic complement-dependent activity and (ii) the E-selectin expression. The K affinity of anti-Gal IgG antibodies was measured by ELISA. Anti-porcine (Gal and non-Gal) IgG antibodies were tested on PAECs by flow cytometry to discriminate the presence of Gal epitopes from the recognition of other porcine epitopes. We found that both anti-porcine IgM and IgG antibodies presented a significantly increased cytolytic activity and E-selectin expression on PAECs during AVR. These characteristics are related to an important increase of the antibody (Ab) titer (especially anti-galactosyl) and a switch to anti-galactosyl IgG1 subclass production, whereas the K affinity remained unchanged. The deleterious effects of both IgM and IgG antibodies observed during AVR showed the crucial need for treatment controlling the cells producing anti-porcine antibodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12199865     DOI: 10.1034/j.1399-3089.2002.01090.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  4 in total

1.  Identification of the V genes encoding xenoantibodies in non-immunosuppressed rhesus monkeys.

Authors:  Annette Kleihauer; Clare R Gregory; Dominic C Borie; Andrew E Kyles; Irina Shulkin; Insiyyah Patanwala; Joanne Zahorsky-Reeves; Vaughn A Starnes; Yoko Mullen; Ivan T Todorov; Mary Kearns-Jonker
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

Review 2.  Bridging innate and adaptive antitumor immunity targeting glycans.

Authors:  Anastas Pashov; Bejatolah Monzavi-Karbassi; Gajendra P S Raghava; Thomas Kieber-Emmons
Journal:  J Biomed Biotechnol       Date:  2010-06-15

3.  Use of molecular modeling and site-directed mutagenesis to define the structural basis for the immune response to carbohydrate xenoantigens.

Authors:  Mary Kearns-Jonker; Natasha Barteneva; Robert Mencel; Namath Hussain; Irina Shulkin; Alan Xu; Margaret Yew; Donald V Cramer
Journal:  BMC Immunol       Date:  2007-03-12       Impact factor: 3.615

4.  Similarities in the immunoglobulin response and VH gene usage in rhesus monkeys and humans exposed to porcine hepatocytes.

Authors:  Joanne L Zahorsky-Reeves; Clare R Gregory; Donald V Cramer; Insiyyah Y Patanwala; Andrew E Kyles; Dominic C Borie; Mary K Kearns-Jonker
Journal:  BMC Immunol       Date:  2006-03-20       Impact factor: 3.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.